Alexion Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ALXN Alexion Pharmaceuticals Inc
NVEC NVE Corp
BAC Bank of America Corp
TTWO Take-Two Interactive Software Inc
CYBE CyberOptics Corp
SJM J M Smucker Co
NKORF Nickel One Resources Inc
NFLX Netflix Inc
MXIM Maxim Integrated Products Inc
MS Morgan Stanley
Go

Health Care : Biotechnology | Large Cap BlendCompany profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

Closing Price
$126.01
Day's Change
0.10 (0.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
128.22
Day's Low
122.68
Volume
(Heavy Day)
Volume:
2,094,946

10-day average volume:
1,327,888
2,094,946
  • Prev Close
    125.91
  • Today's Open
    126.66
  • Day's Range
    122.68-128.22
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    4:00p ET 04/18/19
  • Last (size)
    10.9K
  • 52-Wk Range
    92.56 - 141.86
    LowHigh
  • (12/24/18 - 04/10/19)
    11.17%
  • 36.9%
  • Market Cap
    28.2B
  • Shares Outstanding
    223.5M
  • 0.08
  • 1,640.97x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.5
  • 95.09
  • (% of float 03/29/19)
    1.80

Latest News

April 20, 2019
7:46 am ET
MarketWatch
April 18, 2019
9:33 am ET
Zacks
April 12, 2019
6:30 am ET
BusinessWire
April 04, 2019
10:34 am ET
MarketWatch
9:23 am ET
Zacks
March 20, 2019
7:00 am ET
BusinessWire
6:30 am ET
BusinessWire
March 13, 2019
12:13 pm ET
MarketWatch
March 08, 2019
9:07 am ET
BusinessWire
March 06, 2019
8:34 am ET
Globe Newswire
March 05, 2019
4:30 pm ET
BusinessWire
February 28, 2019
8:30 am ET
BusinessWire
February 22, 2019
2:51 pm ET
BusinessWire
February 21, 2019
4:30 pm ET
BusinessWire
February 14, 2019
8:02 am ET
Globe Newswire
February 13, 2019
7:03 am ET
MarketWatch
February 12, 2019
9:00 am ET
BusinessWire
February 07, 2019
7:54 am ET
Globe Newswire
February 05, 2019
6:34 am ET
MarketWatch
February 04, 2019
6:30 am ET
BusinessWire
February 01, 2019
6:30 am ET
BusinessWire
January 31, 2019
6:31 am ET
BusinessWire
January 28, 2019
6:30 am ET
BusinessWire
January 25, 2019
7:54 am ET
Globe Newswire
January 15, 2019
7:11 am ET
MarketWatch
January 11, 2019
4:43 pm ET
MarketWatch
January 10, 2019
8:01 am ET
MarketWatch
January 04, 2019
7:22 am ET
MarketWatch
December 16, 2018
10:37 am ET
MarketWatch
November 10, 2018
9:54 am ET
MarketWatch
October 24, 2018
7:49 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.